Globus sues J&J over spinal implant; Stryker on the lookout for M&A;

@FierceMedDev: Shorter Tryton side branch stent wins CE mark. Article | Follow @FierceMedDev

@MarkHFierce: J&J is leaving the metal hip replacement business behind. Bloomberg broke a good one: Report | Follow @MarkHFierce

 @DamianFierce: Quest buys Humana's toxicology and clinical lab business. News | Follow @DamianFierce

> Globus Medical ($GMED) is suing Johnson & Johnson ($JNJ), claiming its DePuy unit violated its patent for a spinal implant. Report

> Stryker ($SYK) CEO Kevin Lobo said the medical device giant is still on the hunt for more acquisitions to expand its business. Item

> Indian regulators raided a factory manufacturing medical devices without a license. News

> 2012 Fierce 15 winner CardioDx is touting new data affirming its Corus CAD diagnostic's efficacy in a primary care setting. More

> Taiwan's medical device industry is projected to grow 7% this year. Article

> Devon Medical won a CE mark for its wound therapy system. Story

Biotech News

@FierceBiotech: PPD's BioDuro opens Shanghai discovery lab. FierceCRO story | Follow @FierceBiotech

@JohnCFierce: Amgen, Novartis aim to fuel biotech startups in alliance with Atlas Venture. Report | Follow @JohnCFierce

@RyanMFierce: PTC, bluebird join the IPO frenzy in biotech with genetic therapies. Story | Follow @RyanMFierce

> Sanofi balks on jobs promises at R&D site in Toulouse. Report

> Novo Nordisk completes PhIII hemophilia trial with positive results. Item

> AbbVie, Galapagos extend JAK1 pact into Crohn's disease with $50M carrot. News

> Evotec, Harvard partner up to develop new antibacterials. Story

Pharma News

@FiercePharma: Another pharma deal: Sweden's Recipharm mulls IPO or partial sale, Reuters says. UBS advising. News | Follow @FiercePharma

@EricPFierce: EMA committee backs Bayer's Diane-35 birth control drug, even as off-label acne treatment. Article | Follow @EricPFierce

> Sanofi, France remain at odds over fate of 600 R&D jobs. Article

> India sets controversial price caps on 650 drugs. Story

> GSK tries novel approach in emerging markets: price cuts. Report

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.